Gaudium IVF and Women Health Ltd IPO
Healthcare
Price Band
₹75 – ₹79
Lot Size
189
Minimum Bid Quantity
189
Minimum Investment
₹14931
Issue Size
₹165Cr
Opens
2026-02-20
Closes
2026-02-24
Listing
27-02-2026
Subscription Status
Qualified Institutional Buyers
0.88 x
Non-Institutional Investor
10.94 x
Retail Individual Investor
6.66 x
Total
5.92 x
IPO Details
Issue Type
EQUITY
Face Value
₹5
Tick Size
1
ISIN
INE0P8B01020
Pre-Apply Available
No
Daily Bidding Time
10:00:00 - 17:00:00
About the Company
Gaudium IVF and Women Health is engaged in providing in vitro fertilisation (IVF) treatment and reproductive healthcare services in India. The company offers fertility treatments, including IVF, intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), ovulation induction, frozen embryo transfer (FET), and cryopreservation for egg freezing. It also provides advanced sperm retrieval techniques for male infertility, laparoscopic and hysteroscopic surgeries, and preimplantation genetic testing (PGT). In addition, the company offers gynaecological care for conditions such as PCOD/PCOS and endometriosis, high-risk pregnancy management, nutritional counselling, and psychological support. Incorporated in 2015, the company operates through a hub-and-spoke model with a presence across India. It has seven main centres located in Delhi (Janakpuri and Kailash Colony), Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, supported by additional spoke centres through strategic alliances.
Pros
- • The company claims to follow a structured patient management process that includes dedicated counsellors to guide individuals through fertility treatment. It states that consultations, confidentiality, and treatment transparency are maintained throughout the IVF process, with counselling support integrated into clinical care.
- • Gaudium IVF claims to use next-generation laboratory technology such as INTEGRA Ti™ for ICSI procedures. It also states that it utilises Samsung ultrasound machines, equipment for egg quality evaluation, and clean operating rooms designed to maintain sterility standards.
- • The company claims to provide advanced USG-guided diagnostic and treatment services. These include hysterosalpingography (HSG), ultrasound-guided biopsies, transvaginal scans, follicular monitoring, transrectal ultrasounds, and ovarian cyst aspiration.
Cons
- • As of September 30, 2025, the company had contingent liabilities of Rs 44.99 crore. If any of these contingent liabilities materialise, the company’s financial condition could be adversely affected.
- • The company is highly dependent on doctors, embryologists, gynaecologists, nurses, and other healthcare professionals to operate its fertility centres. Employee attrition rate stood at 31 percent as of September 30, 2025; 63 percent in FY25; 51 percent in FY24, and 51 percent in FY23, indicating significant workforce movement across periods. Any inability to attract or retain qualified medical professionals in a competitive fertility services market may adversely affect the company’s business, operations, and financial condition.
- • The company reported negative cash flow from investing activities amounting to Rs 5.44 crore for the period ended September 30, 2025; Rs 15.17 crore in FY25; Rs 5.40 crore in FY24; and Rs 15.63 crore in FY23. This was primarily due to the purchase of property, plant, and equipment; intangible assets, including right-of-use assets; and investments in non-current investments. Additionally, negative cash flow from financing activities amounted to Rs 1.24 crore in FY24. This was mainly due to dividend payments. The company also reported a net decrease in cash and cash equivalents amounting to Rs 0.60 crore for the period ended September 30, 2025; Rs 4.64 crore in FY25; and Rs 3.20 crore in FY24. If the company is unable to generate sufficient positive cash flows to fund capital expenditure, debt servicing, and working capital requirements, it may adversely affect its business, financial condition, and growth plans.
Get real-time IPO alerts on WhatsApp
Opening reminders • Subscription updates • GMP alerts • Allotment results
Start WhatsApp Alerts